Esperion Therapeutics | ESPR - Operating Profit

Esperion Therapeutics reported $-42513000 in Operating Profit for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Operating Profit Change
Abbvie ABBV:US USD 5.5B 899M
Alnylam Pharmaceuticals ALNY:US USD -188614000 146.01M
Amarin AMRN:US USD -5144000 57.69M
Amgen AMGN:US USD 2.23B 508M
Biogen BIIB:US USD 699.9M 615.2M
Biomarin Pharmaceutical BMRN:US USD -24500000 22.08M
Cytokinetics CYTK:US USD -127030000 3.66M
Daiichi Sankyo 4568:JP JPY 31.55B 29.65B
Eli Lilly And LLY:US USD 1.84B 159.9M
Esperion Therapeutics ESPR:US USD -42513000 890K
Geron GERN:US USD -41951000 2M
Halozyme Therapeutics HALO:US USD 74.51M 6.07M
Heron Therapeutics HRTX:US USD -20355000 21.53M
Intercept Pharmaceuticals ICPT:US USD -18024000 83.88M
Intra Cellular Therapies ITCI:US USD -47412000 8.22M
IONIS PHARMACEUT IONS:US USD -208019000 148.86M
Merk MRK:US USD 3.51B 505M
Minerva Neurosciences NERV:US USD -5070000 137K
Moderna Inc MRNA:US USD 1.58B 414M
Nektar Therapeutics NKTR:US USD -52469000 1.83M
Pfizer PFE:US USD 5.17B 4.24B
Ptc Therapeutics PTCT:US USD -200341000 132.15M
Puma Biotechnology PBYI:US USD -2348000 4.72M
Regeneron Pharmaceuticals REGN:US USD 1.15B 76.9M
Sarepta Therapeutics SRPT:US USD -109408000 147.39M
Seattle Genetics SGEN:US USD -154004000 38.8M
United Therapeutics UTHR:US USD 175.6M 138.7M
Vanda Pharmaceuticals VNDA:US USD 6.63M 2.72M